ACM Global Central Lab Appoints General Manager of Asia Pacific as Global ...Earthtimes (press release)“Since establishing our presence in India in 2006, ACM has become a global leader in the central lab arena,” said Elena Logan, VP of Clinical Trials at ACM ...and more »

Clinical trials come out of closet in IndiaTimes of IndiaAt present, around 600 trials are underway in India," Dr Singh said. "The objective is to restore public confidence in clinical research. ...and more »

Indian CRO Kreara Solutions Pvt Ltd. Joins DATATRAK CRO Connect ProgramPR Newswire (press release)The Company delivers a complete portfolio of software products that were created in order to accelerate clinical research data from investigative sites to ...and more »

2 Teams Advance On Answers To TB Epidemic By Going 'Back To The Drawing Board'Medical News Today (press release)... Fred Hutchinson Cancer Research Center, Seattle, WA; Sarah J. Dunstan, Oxford University Clinical Research Unit, Hospital for Tropical Diseases, ...and more »

Contact: Cathleen GenovaEurekAlert (press release)... Fred Hutchinson Cancer Research Center, Seattle, WA; Sarah J. Dunstan, Oxford University Clinical Research Unit, Hospital for Tropical Diseases, ...and more »

Max Neeman International and AMEDON Collaborate to Increase EDC PerformancePR Newswire (press release)Max Neeman offers a complete Data Management & Biostatistical solution to the clinical research/pharmaceutical industry. The approach is to fulfill client ...and more »

Asia Pharm R&D 2010 - New CRO Trends Become Focus of IndustryPR Newswire (press release)The representative from Transhorsa Translation Ltd. (supporter to the whole translation process) describes this event as a milestone in clinical research ...and more »

PPD opens Ireland research facilityBizjournals.comThe Wilmington-based clinical research organization (Nasdaq: PPDI) has hired 21 people there so far and plans to expand the work force at the site to 250. ...and more »

Lipoxen and Serum Institute of India start Phase II trial for ErepoXenProactive Investors USA & CanadaLipoxen's (AIM: LPX) clinical development partner, the Serum Institute of India, has begun the expanded Phase II trial of ErepoXen. ...and more »

Pharmaceutical Technology MagazineReinvigorating European R&D innovationPharmaceutical Technology Magazine6 The most common factors for failure were lack of efficacy (25%), clinical safety concerns (12%) and toxicological findings in preclinical evaluation (20%) ...and more »